Back to Results
First PageMeta Content
Atypical antipsychotics / Lactams / Organofluorides / Piperidines / Alkermes / Paliperidone / Risperidone / Exenatide / Acorda Therapeutics / Chemistry / Organic chemistry / Psychiatry


ALK corp fact sheet -no tech chart[removed]indd
Add to Reading List

Document Date: 2015-03-03 15:12:35


Open Document

File Size: 337,97 KB

Share Result on Facebook

City

Gainesville / Dublin / Olinger Circle Wilmington / Athlone Co Westmeath / Gould Drive Gainesville / /

Company

Acorda Therapeutics Inc. / AstraZeneca Pharmaceuticals LP. / U.S. Janssen Pharmaceuticals / Biogen Idec / Alkermes Inc. / Johnson & Johnson Corporation / Alkermes plc / Amylin Pharmaceuticals LLC / Athlone Co / Janssen Pharmaceuticals Inc. / M.D. / PETER NORMAN / D. / /

Country

Germany / Japan / Russia / United States / United Kingdom / Ireland / /

Event

FDA Phase / /

Facility

Georgia Facility / Facility Monksland / Massachusetts Facility / Ohio Facility / /

IndustryTerm

biopharmaceutical / /

MedicalCondition

Major Depressive Disorder / serious / chronic diseases / multiple sclerosis / Cancer / schizophrenia / diabetes / CNS diseases / diseases / /

Organization

FDA / European Union / /

Person

MICHAEL J. LANDINE / Depressive Disorder / GEORGIANNA HARRIS / SRDJAN STANKOVIC / Review Aripiprazole Lauroxil (Schizophrenia) / ELLIOT W. EHRICH / RICHARD F. POPS / KATHRYN L. BIBERSTEIN / GORDON G. PUGH / MARK P. STEJBACH / MARK NAMCHUK / REBECCA J. PETERSON / JAMES M. FRATES / /

/

Position

Senior Vice President / Research / Pharmaceutical and Nonclinical Development PETER NORMAN Vice President / Government Policy / Senior Vice President / Clinical Development and Medical Affairs MARK P. STEJBACH / Executive Vice President / Research and Development / and Chief Medical Officer / Vice President / Government Policy and Affairs REBECCA J. PETERSON / Senior Vice President / Corporate Communications Voice / Senior Vice President / Corporate Development / Senior Vice President / Chief Legal Officer and Chief Compliance Officer / and Secretary Alkermes plc MADELINE D. COFFIN Vice President / Human Resources / Vice President / Business Development Voice / Senior Vice President / Chief Commercial Officer / President / Chief Operating Officer and Chief Risk Officer / Vice President / Regulatory Affairs BLAIR C. JACKSON Vice President / Business Development / Chairman and Chief Executive Officer SHANE COOKE President / Senior Vice President / Chief Financial Officer / Senior Vice President / Corporate Communications / Vice President / Government Policy and Affairs / Ph. Senior Vice President / Research / Pharmaceutical and Nonclinical Development PETER NORMAN Vice President / Government Policy / /

Product

LongActing Injection / INVEGA / BYETTA / RISPERDAL / risperidone / VIVITROL / RISPERDAL CONSTA / AMPYRA® (dalfampridine) / Exenatide Once Weekly Suspension / /

ProvinceOrState

Ohio / Georgia / Massachusetts / /

Technology

drug development / /

URL

www.alkermes.com / /

SocialTag